Deep Learning Approaches with Explainable AI for Differentiating Alzheimer Disease and Mild Cognitive Impairment

High diagnostic accuracy achieved: The proposed AI system reached 99.21% accuracy in distinguishing Alzheimer's Disease from Mild Cognitive Impairment, and 91.0% accuracy in differentiating Mild Cognitive Impairment from normal controls, suggesting potential clinical utility for early detection.

Explainability is essential for clinical trust: The researchers integrated Explainable AI techniques (Gradient-weighted Class Activation Mapping) to generate visual heatmaps showing which brain regions influenced the AI's diagnostic decisions, addressing a critical barrier to clinician adoption of AI tools in healthcare.

Ensemble methods improve reliability: By combining three different neural networks (ResNet50, NASNet, and MobileNet) rather than relying on a single model, the framework achieved better performance than individual models, demonstrating that diverse AI approaches can produce more robust medical diagnoses.

Structural brain imaging provides diagnostic signals: The study identified specific gray and white matter changes visible on MRI scans that the AI could use to differentiate disease stages, potentially enabling earlier intervention before symptoms become severe.

Responsible AI requires both performance and interpretability: The research demonstrates that achieving high accuracy alone is insufficient for clinical deployment; the authors prioritized making the AI's reasoning transparent through visualization of which brain regions drove each diagnosis, supporting informed clinical decision-making.